These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35968586)

  • 1. [Chinese consensus for the bispeific T cell engager in the treatment of B-cell acute lymphoblastic leukemia (2022)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):448-455. PubMed ID: 35968586
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal Lymphoid Cells in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Resembling Burkitt Lymphoma Morphology.
    Yu Y; Chen X
    Turk J Haematol; 2023 Aug; 40(3):230-231. PubMed ID: 37338279
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience of CAR T cells for B cell acute lymphoblastic leukemia.
    Fabrizio VA; Curran KJ
    Best Pract Res Clin Haematol; 2021 Sep; 34(3):101305. PubMed ID: 34625231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line.
    Wang L; Zhang Y; Anderson E; Lamble A; Orentas RJ
    Front Immunol; 2022; 13():825364. PubMed ID: 35222407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study.
    Zhou H; Yin Q; Jin J; Liu T; Cai Z; Jiang B; Li D; Sun Z; Li Y; He Y; Ma L; Gao S; Hu J; He A; Du X; Liu D; Zhang X; Ke X; Zhuang J; Han Y; Wang X; Chen Y; Gordon P; Yu D; Zugmaier G; Wang J
    Hematology; 2022 Dec; 27(1):917-927. PubMed ID: 36000952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of KMT2A-MLLT3 fusion-positive mature B-cell acute lymphoblastic leukemia.
    Mitani Y; Arakawa Y; Mori M; Deguchi T; Koh K
    Pediatr Int; 2021 Jun; 63(6):719-722. PubMed ID: 33871895
    [No Abstract]   [Full Text] [Related]  

  • 7. Blinatumomab as bridging therapy in paediatric B-cell acute lymphoblastic leukaemia complicated by invasive fungal disease.
    Yeoh DK; Blyth CC; Kotecha RS
    Br J Haematol; 2022 Sep; 198(5):887-892. PubMed ID: 35727917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
    Kołecki P; Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
    [No Abstract]   [Full Text] [Related]  

  • 9. Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia.
    Locatelli F; Eckert C; Hrusak O; Buldini B; Sartor M; Zugmaier G; Zeng Y; Pilankar D; Morris J; von Stackelberg A
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29715. PubMed ID: 35482538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphometric and electrokinetic criteria of cell identification in acute lymphoblastic leukemia].
    Muskhelishvili LV
    Gematol Transfuziol; 1990 Nov; 35(11):20-2. PubMed ID: 2283021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult acute lymphoblastic leukemia, Burkitt's lymphoma and lymphoblastic lymphoma in middle Norway 1985-2004.
    Lamvik J; Waage A; Wahl SG; Naess I; Paulsen PQ; Hammerstrøm J
    Haematologica; 2006 Oct; 91(10):1428-9. PubMed ID: 17018397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another piece of the puzzle added to understand t(4;11) leukemia better.
    Marschalek R
    Haematologica; 2019 Jun; 104(6):1098-1100. PubMed ID: 31152087
    [No Abstract]   [Full Text] [Related]  

  • 13. A reproducible strategy for analysis of minimal residual disease measured by Standardized multiparametric flow cytometry in b acute lymphoblastic leukemia.
    Sarmiento Palao H; Tarín F; Martirena F; Barragán E; Such E; Sempere A; Tasso M; Manresa P; López F
    Cytometry B Clin Cytom; 2019 Jan; 96(1):12-15. PubMed ID: 30353651
    [No Abstract]   [Full Text] [Related]  

  • 14. Dicentric translocation (9;12) presenting as refractory Philadelphia chromosome-positive acute B-cell lymphoblastic leukemia.
    Bargetzi MJ; Mühlematter D; Tichelli A; Jotterand M; Wernli M
    Cancer Genet Cytogenet; 1999 Aug; 113(1):90-2. PubMed ID: 10459354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinforcing osteopontin as a marker of central nervous system relapse in paediatric B-cell acute lymphoblastic leukaemia: SPP1 splice variant 3 in the spotlight.
    Santoro JC; Bastos ACSF; Gimba ERP; Emerenciano M
    Br J Haematol; 2019 Aug; 186(4):e88-e91. PubMed ID: 30980383
    [No Abstract]   [Full Text] [Related]  

  • 16. Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.
    Ali S; Moreau A; Melchiorri D; Camarero J; Josephson F; Olimpier O; Bergh J; Karres D; Tzogani K; Gisselbrecht C; Pignatti F
    Oncologist; 2020 Apr; 25(4):e709-e715. PubMed ID: 32297447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia.
    Schmidt B; Brown LM; Ryland GL; Lonsdale A; Kosasih HJ; Ludlow LE; Majewski IJ; Blombery P; Ekert PG; Davidson NM; Oshlack A
    Blood Adv; 2022 Jul; 6(14):4093-4097. PubMed ID: 35482550
    [No Abstract]   [Full Text] [Related]  

  • 18. [The consensus of the diagnosis and treatment of adult T-cell lymphoblastic lymphoma in China (2023)].
    ; ;
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):353-358. PubMed ID: 37550183
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment strategy for B cell precursor acute lymphoblastic leukemia in children].
    Koh K
    Rinsho Ketsueki; 2022; 63(7):816-825. PubMed ID: 35922953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
    Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
    Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.